BCL2A1 and nasopharyngeal carcinoma: For example, in nasopharyngeal carcinoma (NPC), CRISPR/Cas9 screening associated to the use of BH3-mimetic drugs helped the identification of those crucial proteins that play an antiapoptotic role in NPC-related treatment resistance, namely BCL-XL, MCL-1 and BFL-1 [62].